Max Healthcare Institute Limited (BOM:543220)
India · Delayed Price · Currency is INR 1,012.20
+3.25 (0.32%)
At close: Jun 12, 2026
Max Healthcare Institute Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Max Healthcare Institute stock has a consensus rating of "Buy" and an average price target of ₹1,149. The average 1-year stock price forecast is 13.47% higher than the current stock price, while the lowest is ₹825.00 (-18.49%) and the highest is ₹1,330 (+31.40%).
Price Target: ₹1,149 (+13.47%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Max Healthcare Institute stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 12 | 13 | 12 | 12 |
| Buy | 8 | 7 | 7 | 7 | 7 | 7 |
| Hold | 4 | 3 | 2 | 2 | 3 | 3 |
| Sell | 2 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 26 | 25 | 25 | 26 | 26 | 26 |
Financial Forecast
Revenue This Year
116.72B
from 83.73B
Increased by 39.39%
Revenue Next Year
138.57B
from 116.72B
Increased by 18.72%
EPS This Year
19.71
from 15.18
Increased by 29.77%
EPS Next Year
24.26
from 19.71
Increased by 23.12%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 130.5B | ||
| Avg | 116.7B | ||
| Low | 94.1B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 55.8% | ||
| Avg | 39.4% | ||
| Low | 12.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 22.89 | ||
| Avg | 19.71 | ||
| Low | 15.68 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 50.8% | ||
| Avg | 29.8% | ||
| Low | 3.3% |